Ascendis Pharma A (ASND) EBITDA Margin (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) EBITDA Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 769.00 |
| Dec 31, 2025 | -277.00 |
| Sep 30, 2025 | 3,865.00 |
| Jun 30, 2025 | 6,972.00 |
| Mar 31, 2025 | -12.37 Mn |
| Dec 31, 2024 | 12.37 Mn |
| Sep 30, 2024 | 20,290.00 |
| Jun 30, 2024 | -31,893.00 |
| Mar 31, 2024 | -3,916.00 |
| Dec 31, 2023 | 26,772.00 |
| Sep 30, 2023 | 1,735.00 |
| Jun 30, 2023 | 13,060.00 |
| Mar 31, 2023 | 21,598.00 |
| Dec 31, 2022 | 30,134.00 |
| Sep 30, 2022 | 135,836.00 |
| Jun 30, 2022 | -42,840.00 |
| Mar 31, 2022 | -174,435.00 |
| Dec 31, 2021 | 857,836.00 |
| Sep 30, 2021 | 280,061.00 |
| Jun 30, 2021 | 519,943.00 |